GOODWILL AND INTANGIBLES ASSETS

12 Months Ended

Dec. 31, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill consisted of the following (in thousands):



	Amount
December 31, 2012	$	9,031
Goodwill from the acquisition of YFind	914
December 31, 2013	$	9,945
Changes in goodwill	—
December 31, 2014	$	9,945

Intangible assets consisted of the following (in thousands, except years):



	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Weighted Average Remaining Life
December 31, 2014
Purchased technology	$	12,600	$	(5,249	)	$	7,351	2.8 years

December 31, 2013
Purchased technology	$	6,600	$	(2,929	)	$	3,671	2.8 years
In-process research and development	6,000		—			6,000
Total	$	12,600	$	(2,929	)	$	9,671

On July 18, 2013, the Company recorded the fair value of the in-process research and development of $6.0 million related to the acquisition of YFind. In-process research and development was accounted for as an indefinite-lived intangible asset, until its completion on May 1, 2014. Following its completion, it was transferred to purchased technology and is being amortized over its estimated useful life of four years.

Amortization expense related to the purchased technology was $2.3 million, $1.3 million and $1.3 million for the years ended December 31, 2014, 2013 and 2012, respectively. Amortization expense is included as a component of cost of revenue in the accompanying consolidated statements of operations.

The following table presents the estimated future amortization expense of intangible assets as of December 31, 2014 (in thousands):



Year ending December 31,	Amount
2015	$	2,820
2016	2,531
2017	1,500
2018	500
Total amortization	$	7,351

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details